Registered entities
Delix Therapeutics, Inc
Reg. No. 84-2512594United States
Innovation
22 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 485 times.
| Year | Filings |
|---|---|
| 2021 | 3 |
| 2023 | 10 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 4 |
Social engagement
Social engagement: 9.9K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
24 investors on record; lead investors include Artis Ventures, RA Capital Management, OMX Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 16 | 67% |
| Private equity | 1 | 4% |
| Other / undisclosed | 7 | 29% |
Recent activity
3 Oct 2025
Partnership
Cumulus Neuroscience